Johnson, Tony

Donepezil and memantine for moderate-to-severe Alzheimer's disease

Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 782

Cognitive–behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial

Scott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T., Abbott, R., & Hayhurst, H. (2006) · British Journal of Psychiatry

Bipolar Disorder and TreatmentPersonality Disorders and Psychopathology

Cited by 566

Personality disorder and the outcome of depression: Meta-analysis of published studies

Newton-Howes, G., Tyrer, P., & Johnson, T. (2006) · British Journal of Psychiatry

Personality Disorders and PsychopathologyAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 537

Donepezil for the Treatment of Agitation in Alzheimer's Disease

Howard, R. J., Juszczak, E., Ballard, C. G., Bentham, P., Brown, R. G., Bullock, R., Burns, A. S., Holmes, C., Jacoby, R., Johnson, T., et al. (2007) · New England Journal of Medicine

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 327

Determining the minimum clinically important differences for outcomes in the DOMINO trial

Howard, R., Phillips, P., Johnson, T., O'Brien, J., Sheehan, B., Lindesay, J., Bentham, P., Burns, A., Ballard, C., Holmes, C., et al. (2011) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchStatistical Methods in Clinical Trials

Cited by 185

The Nottingham Study of Neurotic Disorder: predictors of 12-year outcome of dysthymic, panic and generalized anxiety disorder

TYRER, P., SEIVEWRIGHT, H., & JOHNSON, T. (2004) · Psychological Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 119